Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in BRCA-mutated or BRCAness advanced ovarian cancer
NCT01772979Phase 2Unknown
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Jun 2011
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in ovarian cancer, sponsored by Università Cattolica del Sacro Cuore. Status: unknown.
02
Drugs
trabectedin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01772979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01772979.